Year |
Citation |
Score |
2015 |
Vaishya RD, Mandal A, Gokulgandhi M, Patel S, Mitra AK. Reversible hydrophobic ion-paring complex strategy to minimize acylation of octreotide during long-term delivery from PLGA microparticles. International Journal of Pharmaceutics. 489: 237-45. PMID 25940041 DOI: 10.1016/J.Ijpharm.2015.04.075 |
0.551 |
|
2014 |
Vaishya RD, Gokulgandhi M, Patel S, Minocha M, Mitra AK. Novel dexamethasone-loaded nanomicelles for the intermediate and posterior segment uveitis. Aaps Pharmscitech. 15: 1238-51. PMID 24895075 DOI: 10.1208/S12249-014-0100-4 |
0.744 |
|
2014 |
Patel M, Mandava N, Gokulgandhi M, Pal D, Mitra AK. Amino Acid Prodrugs: An Approach to Improve the Absorption of HIV-1 Protease Inhibitor, Lopinavir. Pharmaceuticals (Basel, Switzerland). 7: 433-52. PMID 24727459 DOI: 10.3390/Ph7040433 |
0.71 |
|
2014 |
Barot M, Gokulgandhi MR, Pal D, Mitra AK. In vitro moxifloxacin drug interaction with chemotherapeutics: implications for retinoblastoma management. Experimental Eye Research. 118: 61-71. PMID 24157270 DOI: 10.1016/J.Exer.2013.10.009 |
0.725 |
|
2014 |
Barot M, Gokulgandhi MR, Agrahari V, Pal D, Mitra AK. Monocarboxylate transporter mediated uptake of moxifloxacin on human retinal pigmented epithelium cells. The Journal of Pharmacy and Pharmacology. 66: 574-83. PMID 24102496 DOI: 10.1111/Jphp.12139 |
0.711 |
|
2013 |
Barot M, Gokulgandhi MR, Patel S, Mitra AK. Microvascular complications and diabetic retinopathy: recent advances and future implications. Future Medicinal Chemistry. 5: 301-14. PMID 23464520 DOI: 10.4155/Fmc.12.206 |
0.688 |
|
2013 |
Patel M, Dalvi P, Gokulgandhi M, Kesh S, Kohli T, Pal D, Mitra AK. Functional characterization and molecular expression of large neutral amino acid transporter (LAT1) in human prostate cancer cells. International Journal of Pharmaceutics. 443: 245-53. PMID 23270998 DOI: 10.1016/J.Ijpharm.2012.12.029 |
0.605 |
|
2013 |
Gaudana R, Gokulgandhi M, Khurana V, Kwatra D, Mitra AK. Design and evaluation of a novel nanoparticulate-based formulation encapsulating a HIP complex of lysozyme. Pharmaceutical Development and Technology. 18: 752-9. PMID 23137392 DOI: 10.3109/10837450.2012.737806 |
0.671 |
|
2013 |
Barot M, Gokulgandhi MR, Pal D, Mitra AK. Mitochondrial localization of P-glycoprotein and peptide transporters in corneal epithelial cells--novel strategies for intracellular drug targeting. Experimental Eye Research. 106: 47-54. PMID 23116562 DOI: 10.1016/J.Exer.2012.10.006 |
0.707 |
|
2012 |
Gokulgandhi MR, Vadlapudi AD, Mitra AK. Ocular toxicity from systemically administered xenobiotics. Expert Opinion On Drug Metabolism & Toxicology. 8: 1277-91. PMID 22803583 DOI: 10.1517/17425255.2012.708337 |
0.722 |
|
2012 |
Barot M, Bagui M, Gokulgandhi MR, Mitra AK. Prodrug strategies in ocular drug delivery. Medicinal Chemistry (ShāRiqah (United Arab Emirates)). 8: 753-68. PMID 22530907 DOI: 10.2174/157340612801216283 |
0.735 |
|
2012 |
Gokulgandhi MR, Barot M, Bagui M, Pal D, Mitra AK. Transporter-targeted lipid prodrugs of cyclic cidofovir: a potential approach for the treatment of cytomegalovirus retinitis. Journal of Pharmaceutical Sciences. 101: 3249-63. PMID 22499243 DOI: 10.1002/Jps.23140 |
0.706 |
|
2012 |
Gaudana RJ, Gokulgandhi MR, Boddu SH, Mitra AK. Recent overview of ocular patents. Recent Patents On Drug Delivery & Formulation. 6: 95-106. PMID 22493994 DOI: 10.2174/187221112800672921 |
0.715 |
|
2011 |
Barot M, Gokulgandhi MR, Mitra AK. Mitochondrial dysfunction in retinal diseases. Current Eye Research. 36: 1069-77. PMID 21978133 DOI: 10.3109/02713683.2011.607536 |
0.69 |
|
2011 |
Barot M, Gokulgandhi MR, Haghnegahdar M, Dalvi P, Mitra AK. Effect of emergence of fluoroquinolone resistance on intrinsic expression of P-glycoprotein phenotype in corneal epithelial cells. Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association For Ocular Pharmacology and Therapeutics. 27: 553-9. PMID 21830912 DOI: 10.1089/Jop.2011.0076 |
0.7 |
|
2010 |
Barot M, Gokulgandhi MR, Parikh JR. Trends in ophthalmic preservatives: A review Drug Delivery Technology. 10: 46-49. |
0.673 |
|
Show low-probability matches. |